All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

THE GOOD
Approvals & Labels

FDA approves Regeneron's Evkeeza (ANGPTL3 inhibitor) for homozygous familial hypercholesterolemia in children ages 1-5
Antibody, metabolic, monoclonal antibody, familial hypercholesterolemia, ANGPTL3 inhibitor, pediatric population - Read more

Eisai's LEQEMBI anti-amyloid antibody gains China approval for monthly maintenance dosing in early Alzheimer's disease
Monoclonal antibody, neurological, Alzheimer disease, amyloid-beta target, maintenance dosing - Read more

THE GOOD
Business Development & Partnerships

PharmAla partners with Veridion as exclusive MDMA distributor in New Zealand, includes annual purchase minimum
Distribution agreement, MDMA, pharmaceutical, regulatory, international, regional distribution - Read more

OSE Immunotherapeutics, Inserm Transfert, Nantes University partner to develop immunotherapy innovations for oncology, inflammation, and autoimmunity
Research collaboration, oncology, autoimmune, immunotherapy, R&D, academic-industry partnership - Read more

Novatim, VRise: License deal for dual-target CAR-T therapy in India includes upfront payment, milestones, royalties
Licensing deal, cell therapy, autoimmune, India, milestone payments, royalties - Read more

PRESENTED BY YOU?
Get the attention of 2200+ Biotech & Pharma Professionals 🤩

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

✅ More Good News ✅

THE GOOD
Clinical Trials

China Medical System's ruxolitinib cream achieves 63% IGA success in Ph3 atopic dermatitis trial
Small molecule, autoimmune, JAK inhibitor, atopic dermatitis, topical treatment - Read more

THE GOOD
Fundraises

biotopeby VIB raises €350K ($408K) seed funding for three biotech startups advancing planetary health
Biotech incubator, early-stage investor, startup accelerator, platform technology, services - Read more

Cure Alzheimer's Fund receives $50M gift to support Alzheimer's disease research initiatives
Alzheimer disease, nonprofit, research funding, neurological - Read more

THE GOOD
Investments

Eli Lilly opens San Diego biotech incubator for up to 15 companies, with several already onboard
Biotech infrastructure, strategic, operational, ecosystem development, investment - Read more

Amgen invests $650M to expand Puerto Rico manufacturing site, creating hundreds of jobs amidst US production push
Biologics manufacturing, manufacturing expansion, operational, strategic, financial investment - Read more

Concept Life Sciences expands integrated drug discovery facility in Chapel-en-le-Frith, creating 130-scientist research hub
Drug discovery services, CRO expansion, operational, strategic - Read more

THE GOOD
Mergers & Acquisitions

Lotus Pharmaceuticals acquires Alvogen in $2 billion deal, creating top-20 specialty pharma company with expanded US presence
Generics, specialty pharmaceuticals, strategic, major acquisition, global expansion - Read more

THE GOOD
Politics & Policy

ARPA-H launches two 9-figure programs to expand access to personalized gene editing therapies for rare diseases
Gene editing, rare disease, strategic, regulatory, investment - Read more

THE GOOD
Product Launches

BMS launches Patient Connect platform offering Sotyktu at 86% discount for cash-paying psoriasis patients
Small molecule, autoimmune, pricing strategy, patient access, direct-to-consumer, financial - Read more

AstraZeneca launches direct-to-consumer platform offering 70% discounts on Farxiga and Airsupra medications starting October 1
Small molecule, diabetes, direct-to-consumer, pricing strategy, patient access, commercial - Read more

THE GOOD
Strategic Plans

Sanofi caps all insulin products at $35 monthly regardless of insurance status, starting 2026
Insulin, diabetes, pricing strategy, patient access, financial impact - Read more

THE BAD
Clinical Trials

MoonLake's IL-17A/F inhibitor sonelokimab shows mixed Ph3 results for hidradenitis suppurativa with one trial succeeding
Protein therapy, autoimmune, IL-17 inhibitor, hidradenitis suppurativa, nanobody - Read more

THE BAD
Politics & Policy

Trump administration proposes GLOBE Model rule to match US drug prices with lowest international rates
Drug pricing policy, healthcare economics, regulatory, strategic, financial - Read more

Trump announces 100% pharmaceutical tariffs with key exemptions for generics and European exports
Drug pricing policy, trade policy, financial, regulatory, strategic - Read more

UK plans to pay more for certain NHS drugs to ease tensions with Trump administration
Pharmaceutical policy, international trade, strategic, financial, regulatory - Read more

THE UGLY
Politics & Policy

Trump's drug pricing policy discourages US biotechs from European licensing deals over price control fears
Drug pricing, policy, strategic, market access, international commerce - Read more

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here